Changes in blood hemoglobin and blood gases PaO2 and PaCO 2 in severe COPD over a three-year telemonitored program of long-term oxygen treatment

Multidisciplinary Respiratory Medicine

Volumn 7, Issue 2, 2012, Pages

  Dal Negro, Roberto W ^a   Tognella, Silvia ^a   Bonadiman, Luca ^b   Turco, Paola ^b  

^a Ospedale 2   (Italy)

^b National Centre of Studies of Pharmacoeconomics and Respiratory Pharmacoepidemiology (CESFAR)   (Italy)

Author keywords

Anemia; COPD; Hemoglobin; LTOT; Polyglobulia; Telemedicine

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; HEMOGLOBIN; LONG ACTING DRUG; OXYGEN;

ADULT; AGED; ANEMIA; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL GAS; ARTERIAL OXYGEN SATURATION; ARTERIAL OXYGEN TENSION; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY FAILURE; COHORT ANALYSIS; CORTICOSTEROID THERAPY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OXYGEN THERAPY; OXYGENATION; POLYCYTHEMIA; SURVIVAL; TELEMONITORING;

EID: 84866262383     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/2049-6958-7-15     Document Type: Article

References (32)

1. : Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2009. [http://www.goldcopd.com].
2. Stradling JR, Lane DJ: Development of secondary polycythaemia in chronic airways obstruction. Thorax 1981, 36:321-325.
3. Similowski T, Agustí A, MacNee W, Schönhofer B: The potential impact of anaemia of chronic disease in COPD. Eur Respir J 2006, 27:390-396. (Pubitemid 43180920)
4. Bateman AP, McArdle F, Walsh TS: Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis. Crit Care Med 2009, 37:1906-1912.
5. Mansen TJ, McCance KL, Parker-Cohen PD: Alterations of erythrocyte function. In Pathophysiology: The Biologic Basis for Disease in Adults and Children. 2nd edition. Edited by McCance KL, Huether SE. St. Louis: Mosby-Year Book; 1994:860-877.
6. John M, Lange A, Hoernig S, Witt C, Anker SD: Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases. Int J Cardiol 2006, 111:365-370. (Pubitemid 44205291)
7. O'Reilly P, Bailey W: Long-term continuous oxygen treatment in chronic obstructive pulmonary disease: proper use, benefits and unresolved issues. Curr Opin Pulm Med 2007, 13:120-124. (Pubitemid 46175108)
8. Dal Negro RW: Long term oxygen tele-home monitoring, the Italian perspective. Chest Companion Book. 2000:247-249.
9. Dal Negro RW, Turco P: Telemedicine and LTOT in Italy: a 20 year experience. In Home Long-Term Oxygen treatment in Italy. The additional value of telemedicine. Edited by Dal Negro RW, Goldberg AI. Heidelberg: Springer Verlag; 2005:69-83.
10. Dal Negro RW, Aquilani R, Bertacco S, Boschi F, Micheletto C, Tognella S: Comprehensive effects of supplemented essential amino acids in patients with severe COPD and sarcopenia. Monaldi Arch Chest Dis 2010, 73:25-33.
11. Gex G, Janssens JP: Long-term oxygen therapy. Rev Med Suisse 2007, 3 (2646):2648-2650. 2652-2654.
12. Anthonisen NR: Long-term oxygen therapy. Ann Intern Med 1983, 99:519-527.
13. Penninx BW, Pahor M, Cesari M, Corsi AM, Woodman RC, Bandinelli S, Guralnik JM, Ferrucci L: Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc 2004, 52:719-724. (Pubitemid 38596489)
14. Weiss G, Goodnough LT: Anemia of chronic disease. N Engl J Med 2005, 352:1011-1023.
15. Agustí AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X: Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003, 21:347-360. (Pubitemid 36204553)
16. National Kidney Foundation: NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis 2001, 37(Suppl. 1):S182-S238.
17. Silberberg JS, Rahal DP, Patton DR, Sniderman AD: Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease. Am J Cardiol 1989, 64:222-224. (Pubitemid 19179369)
18. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J: Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002, 39:1780-1786. (Pubitemid 34595288)
19. McMurray JJ: What are the clinical consequences of anemia in patients with chronic heart failure? J Card Fail 2004, 10(1 Suppl):S10-S12.
20. Sharma R, Francis DP, Pitt B, Poole-Wilson PA, Coats AJ, Anker SD: Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. Eur Heart J 2004, 25:1021-1028. (Pubitemid 38869420)
21. Belperio PS, Rhew DC: Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med 2004, 116(Suppl 7A):27S-43S.
22. Volberding P: The impact of anemia on quality of life in human immunodeficiency virus-infected patients. J Infect Dis 2002, 185 (Suppl. 2):S110-S114.
23. Pockros PJ, Shiffman ML, Schiff ER, Sulkowski MS, Younossi Z, Dieterich DT, Wright TL, Mody SH, Tang KL, Goon BL, Bowers PJ, Leitz G, Afdhal NH, PROACTIVE Study Group: Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy. Hepatology 2004, 40:1450-1458. (Pubitemid 39657021)
24. Kroeker EJ, Leon AS: The association of diffuse obstructive pulmonary emphysema and chronic gastroduodenal ulceration. Dis Chest 1962, 42:413-421.
25. Caro JJ, Salas M, Ward A, Goss G: Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 2001, 91:2214-2221. (Pubitemid 32552805)
26. Chambellan A, Chailleux E, Similowski T, ANTADIR Observatory Group: Prognostic value of hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 2005, 128:1201-1208. (Pubitemid 41324396)
27. DeFilippis AP, Law K, Curtin S, Eckman JR: Blood is thicker than water: the management of hyperviscosity in adults with cyanotic heart disease. Cardiol Rev 2007, 15:31-34. (Pubitemid 46005946)
28. Graudal N, Galløe AM, Nielsen OJ: Erythropoietin in chronic obstructive pulmonary disease. Relationship between serum erythropoietin, blood haemoglobin and lung function-effect of the calcium antagonist isradipine on serum erythropoietin. Respiration 1991, 58:141-144.
29. Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B: Haemoglobin level and its clinical impact in a cohorty of patients with COPD. Eur Respir J 2007, 29:923-929. (Pubitemid 46711896)
30. Tassiopoulos S, Kontos A, Konstantopoulos K, Hadzistavrou C, Vaiopoulos G, Aessopos A, Tassiopoulos T: Erythropoietic response to hypoxaemia in diffuse idiopathic pulmonary fibrosis, as opposed to chronic obstructive pulmonary disease. Respir Med 2001, 95:471-475. (Pubitemid 32622000)
31. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP: Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160:1856-1861. (Pubitemid 30004687)
32. Deng X, Cai Y, Fang Z: The effects of long-term domiciliary oxygen therapy on patients of chronic obstructive pulmonary disease with hypoxaemia. Zhonghua Jie He He Hu Xi Za Zhi 2001, 24:655-659.